InMode Optimas
IPL multi-app platform · Platform hosting Lumecca + Diolaze + RF
What it's actually cleared for: Diolaze XL cleared under K180719 (2018): 810nm handpiece for hair removal and permanent hair reduction, with 755/810 and 810/1064 blends. Lumecca is cleared under separate InMode 510(k)s for benign pigmented epidermal and cutaneous vascular lesions — verify the specific K-number for the exact Lumecca variant on your quote. The Optimas platform is a chassis; clearances attach to applicators.
Last verified: August 6, 2026 · How we verify
New: $90k–$130k|Used: $40k–$70kmarket estimate, no email required
Bottom line
InMode's workhorse multi-application platform, and the Lumecca + Diolaze XL pairing is the classic cash-flow config — IPL photofacials and laser hair removal are the two highest-volume entry treatments in any medspa. It won't differentiate you like a Morpheus8 or Ultherapy, but it fills the schedule with essentially no per-treatment consumable cost. Never pay sticker — aggressive-list/heavy-discount is InMode sales culture, and the used market is deep. A revenue utility, not a marketing centerpiece.
Overview
Workstation for IPL and diode HR
How it works
The science
A chassis powering interchangeable optical and RF handpieces. Lumecca is high-peak-power IPL (roughly 515/580nm cutoffs) targeting melanin and hemoglobin — sun damage, lentigines, rosacea, telangiectasia; InMode's pitch is higher peak power clears pigment in 1-2 sessions versus 3-5 for commodity IPLs. Diolaze XL is a large-spot diode (810nm core; 755/810 and 810/1064 blends) for hair removal with contact cooling. Both non-invasive, no downtime.
Patented tech
Lumecca is branded high-peak-power IPL — a xenon flashlamp with tighter pulse control, not a new physics category. Diolaze XL's claim is one of the larger diode spots on the market plus built-in cooling — refined diode engineering.
Origin
Yokneam, Israel (InMode).
FDA & regulatory status
What it's actually cleared for:
Diolaze XL cleared under K180719 (2018): 810nm handpiece for hair removal and permanent hair reduction, with 755/810 and 810/1064 blends. Lumecca is cleared under separate InMode 510(k)s for benign pigmented epidermal and cutaneous vascular lesions — verify the specific K-number for the exact Lumecca variant on your quote. The Optimas platform is a chassis; clearances attach to applicators.
Regulatory data is compiled from public FDA 510(k) records and may lag recent clearances. Always confirm status with the manufacturer before purchase.
Treatment economics
What practices charge
Lumecca photofacials $350-600/session, series of 2-3 ($900-1,500). Diolaze by area — $100-250 small, $300-600 large per session in 6-packs. A busy mixed IPL/LHR room grosses $15k-30k/month off this platform alone.
Consumables & recurring cost
Effectively none per treatment — the core margin story. Reality check: IPL flashlamps and diode stacks degrade with pulse count; budget handpiece refurb (several thousand each) every few years plus ~$8k-15k/year service post-warranty.
Ideal for
Best-fit practice
New or growth-stage medspas needing bread-and-butter volume, and sunny-market practices with heavy pigment/rosacea demand. Broad 25-60 patient base; diode LHR requires caution on V-VI (the 1064 blend helps). Poor fit if you already own a competent IPL and LHR device.
Compliance
Medical director & delegation
IPL and Class IV diode fall under state laser rules — physician or mid-level oversight with delegated treatment by RNs or licensed aestheticians/techs, varying widely.
Contraindications & screening
Recent tanning or active melasma flare (IPL), pregnancy, photosensitizers, active infection/lesions in the field, keloid history, darker Fitzpatrick types on the 810-only handpiece.
Ownership
Warranty & service
1-year standard; extended sold hard at closing. InMode's US service network is large but field responsiveness gets mixed owner reviews — budget for loaner-gap downtime.
Resale & used market
One of the most liquid platforms in the used market — Optimas with Lumecca/Diolaze lists constantly at $35k-75k by handpiece count and pulse counts. Values drifting down as InMode discounts new units; expect steep depreciation from list.
Chains using this device
No confirmed chain deployments recorded yet.
Owner reviews
Write a reviewNo approved reviews yet. Be the first owner to publish one.
Alternatives
History
Every tracked change to pricing, lifecycle status, FDA data and warranty terms — newest first.
August 1, 2026
Record created
Added to The Aesthetic Index — August 2026
Source: The Aesthetic Index editorial
Get the full State of Aesthetic Devices 2026 report
The first independent census of the US aesthetic device market — free.